Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial - The Lancet
Accelerated Infliximab Infusion: Safety, Factors Predicting Adverse Events, Patients' Satisfaction and Cost Analysis. A Cohort
Infliximab
Colectomy free survival. Infliximab 5 versus 10 mg/kg induction. | Download Scientific Diagram
Protocol for administration of infliximab for acute severe ulcerative... | Download Scientific Diagram
Infliximab retreatment results in remission in 35% of patients with Crohn's disease
![PDF] Induction with Infliximab and a Plant-Based Diet as First-Line (IPF) Therapy for Crohn Disease: A Single-Group Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2fc9045bc7e9db2c6013161a8a274e4c7eec236c/2-Figure1-1.png "PDF] Induction with Infliximab and a Plant-Based Diet as First-Line (IPF) Therapy for Crohn Disease: A Single-Group Trial. | Semantic Scholar")
PDF] Induction with Infliximab and a Plant-Based Diet as First-Line (IPF) Therapy for Crohn Disease: A Single-Group Trial. | Semantic Scholar
JCM | Free Full-Text | Therapeutic Drug Monitoring of Subcutaneous Infliximab in Inflammatory Bowel Disease—Understanding Pharmacokinetics and Exposure Response Relationships in a New Era of Subcutaneous Biologics
Acute severe colitis: Accelerated induction Infliximab | Digestive Disease Dashboard
Remission rate after infliximab induction therapy | Download Table
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis | NEJM
JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
Infliximab
JCM | Free Full-Text | A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease
A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy | Arthritis Research & Therapy | Full
Efficacy and tolerability of infliximab retreatment in patients with inflammatory bowel disease: a systematic review and meta-analysis - Seungwon Yang, Siyoung Yang, Young Kwon Jo, Seungyeon Kim, Min Jung Chang, Junjeong Choi,
IV Infliximab infusion protocol
Review article: dose optimisation of infliximab for acute severe ulcerative colitis - Hindryckx - 2017 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Infliximab (Remicade).pdf - Marquette General Hospital
Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis - Clinical Gastroenterology and Hepatology
Remicade Dosage Guide - Drugs.com
JCM | Free Full-Text | Levels of Biosimilar Infliximab during and after Induction Treatment in Crohn's Disease and Ulcerative Colitis—A Prospective Polish Population Study
Frontiers | Early Serum Infliximab Levels in Pediatric Ulcerative Colitis
Prognostic factors for long‐term infliximab treatment in Crohn's disease patients: a 20‐year single centre experience - Billiet - 2016 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Clinical response after a single infliximab infusion versus three-dose... | Download Scientific Diagram
